At the last World Orphan Drug Congress Asia in 2013, the audience were fortunate to hear from Zen-Ichi Mohri of JCR Pharmaceuticals., Co Ltd. He …
Whitepaper: A new communications model for rare diseases
Rare diseases present distinct communication requirements and opportunities. While fundamental medical communications principles are universal, the specific characteristics of rare diseases demand a new, highly …
Download: How to access the Brazilian orphan drug market
As market access strategies become an essential milestone to improve the global access to orphan drugs, huge markets like Brazil are poised to support the …
Whitepaper: Adaptive Clinical Trials
For orphan drug development, clinical trials can pose an insurmountable barrier to getting a product to market. This is especially true for substances looking to …
Interview: What investors are looking for in orphan drug biotechs
Following the growth of the orphan drug industry and the increasing appetite of investors, we interviewed Patrick Enright, Managing Director of Menlo Park based venture …
How to generate leads – the top ten tips in generating marketing qualified leads
The orphan drugs and rare disease community is, by its very nature, niche. As such it can be hard to reach your target audience, and …
Download ebook: Patient group insights into the orphan drug industry
Over the past few months we have been speaking with representatives from various patient groups across Asia trying to gain a better understanding of how …
Download: Novartis on the power of rare diseases – found in translation
Novartis kindly provided this article on the topic, ‘The power of rare diseases: found in translation.’ It was originally published in Science. Download a copy …